🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
Primary Objectives: * Phase 1: To characterize the safety and tolerability...
Status
Terminated
Location
Investigational Site Number :8400003
Start Date
2020-06-18
Trial ID
NCT04294459
The purpose of this study is to examine the combination of one standard tre...
Status
Completed
Location
Robert Wood Johnson University Hospital at Hamilton
Start Date
2011-12-23
Trial ID
NCT01649947
Treatments Being Tested
This is a multicentre phase III open-labelled, randomised controlled trial....
Status
Completed
Location
Rigshospitalet
Start Date
2013-01-24
Trial ID
NCT01726452
After failure on docetaxel, which has been the standard first line therapy ...
Status
Unknown
Location
Reinier de Graaf Groep
Start Date
2017-02-21
Trial ID
NCT03050866
Treatments Being Tested
In December 2019, Wuhan, in Hubei province, China, became the center of an ...
Status
Completed
Location
Hospital Universitario Hm Montepríncipe
Start Date
2020-05-12
Trial ID
NCT04382066
Treatments Being Tested
The purpose of this study is to see if the combination of bendamustine, len...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2008-02
Trial ID
NCT01042704
The purpose of this study is to explore the combination of Elotuzumab in co...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2016-01
Trial ID
NCT02655458
Treatments Being Tested
This is an investigator-initiated (IIS), phase 2, prospective, open-label, ...
Status
Unknown
Location
General Hospital of Athens "Evangelismos"
Start Date
2022-05
Trial ID
NCT05298683